About Us

Archives






BioAegis Therapeutics Announces Publication of a Compassionate Use Case Study of a Critical COVID-19 Patient

Posted: August 29, 2021 at 1:49 am


Gelsolin immunomodulator treatment associated with patient’s rapid recovery.

Link:
BioAegis Therapeutics Announces Publication of a Compassionate Use Case Study of a Critical COVID-19 Patient

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.